Zentalis Pharmaceuticals (ZNTL) Revenue (2024)
Zentalis Pharmaceuticals (ZNTL) recorded quarterly Revenue of $26.9 million in Q4 2024, down 33.76% quarter-over-quarter from $40.6 million in Q1 2024.
Zentalis Pharmaceuticals (ZNTL) Revenue (2024) Analysis & Trends
Zentalis Pharmaceuticals' Revenue history runs 1 years deep, the most recent figure standing at $26.9 million for Q4 2024.
- In Q4 2024, Revenue changed N/A year-over-year to $26.9 million; the TTM figure through Sep 2025 stood at $26.9 million (down 33.76% YoY), while the FY2024 annual figure was $67.4 million, changed N/A from the prior year.
- Revenue was $26.9 million for Q4 2024 at Zentalis Pharmaceuticals, down from $40.6 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $40.6 million in Q1 2024 to a low of $26.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zentalis Pharmaceuticals | 260.33 Mn | 260.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 26.87 Mn |
| Mar 31, 2024 | 40.56 Mn |